Pancreaticobiliary versus head and neck presentation of immunoglobulin G4-related disease: different sides of the same coin?. Issue 1 (27th January 2023)

• Record Type: Journal Article
• Authors: Awadelkarim, Bidour; Vila, Josephine; Nayar, Manu K; Leeds, John S; Griffiths, Bridget; Oppong, Kofi W
• Is Part Of: BMJ open gastroenterology. Volume 10:Issue 1(2023)
• Publication Date: 2023-01-27
• Subjects: PANCREATITIS -- BILIARY STRICTURES -- PANCREATIC DISORDERS -- PANCREATIC DISEASE; Gastroenterology -- Periodicals; 616.33005
• DOI: 10.1136/bmjgast-2022-000961
• Languages: English
• ISSNs: 2054-4774

Abstract

Abstract : Background and study aim: Immunoglobulin G4-related disease (IgG4-RD) is a rare immune mediated fibroinflammatory condition. Pancreaticobiliary (PB) and head and neck (HN) are two of the most commonly involved anatomical sites. It has been postulated that PB IgG4-RD and HN IgG4-RD have distinct clinical phenotypes. Whether the optimum treatment regimen or response to therapy differs between them is unknown. We aimed to assess differences between PB and HN IgG4-RD in a cohort of IgG4 disease managed by an IgG4-RD multispecialty team. Methods: We performed a retrospective study of a prospectively maintained multidisciplinary IgG4-RD database to identify patients diagnosed with PB and HN IgG4-RD (based on initial presentation) between 2005 and 2019. The electronic patient records were reviewed. Use of immunosuppressive agents and clinical course was analysed. Results: 60 patients with PB IgG4-RD and 14 with HN IgG4-RD were included in the study. PB IgG4-RD was associated with older age at diagnosis 64 versus 51 years (p<0.001), higher serum IgG4 level as a multiple of upper limit of normal median (IQR) 2 (1–3.75) vs 1 (1–2), (p=0.04) and greater proportion with more than one organ involved 68% vs 33% (p=0.03). HN IgG4-RD was more likely to receive second-line therapy 71% versus 36% (p=0.03). Persistent elevation of serum IgG4 after therapy was more common in PB IgG4-RD 84% versus 43% (p=0.03). Conclusion: These findings support the contention that PB IgG4-RD and HN IgG4-RD have different clinical profiles and represent distinct subtypes of IgG4-RD.